pentosidine has been researched along with Apoplexy in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bocian, K; Fiszer, U; Korczak-Kowalska, G; Leńska-Mieciek, M | 1 |
| Ikeda, T; Ito, N; Maruyama, K; Nagane, M; Shiokawa, Y; Utagawa, A | 1 |
2 other study(ies) available for pentosidine and Apoplexy
| Article | Year |
|---|---|
Pentosidine, advanced glycation end product, in acute ischaemic stroke patients with and without atrial rhythm disturbances.
Topics: Arginine; Atrial Fibrillation; Brain Ischemia; Carotid Intima-Media Thickness; Humans; Lysine; Risk Factors; Stroke | 2020 |
Serum pentosidine, an advanced glycation end product, indicates poor outcomes after acute ischemic stroke.
Topics: Aged; Arginine; Biomarkers; Cohort Studies; Female; Glycation End Products, Advanced; Hospitalization; Humans; Logistic Models; Lysine; Male; Prognosis; Prospective Studies; Risk Assessment; Risk Factors; Stroke | 2012 |